@article{ref1,
title="Does Assertive Community Treatment Increase Medication Adherence for People With Co-occurring Psychotic and Substance Use Disorders?",
journal="Journal of the American Psychiatric Nurses Association",
year="2011",
author="Manuel, Jennifer I. and Covell, Nancy H. and Jackson, Carlos T. and Essock, Susan M.",
volume="17",
number="1",
pages="51-56",
abstract="OBJECTIVE: This study analyzed data from a randomized trial to examine the impact on medication adherence of integrated treatment delivered via assertive community treatment (ACT) versus standard clinical case management (SCCM). METHOD: Data from the original study included 198 study participants with co-occurring psychotic and substance use disorders who were randomly assigned to receive integrated treatment via ACT or SCCM and were followed for 3 years. We applied mixed-effects logistic regression to estimate group (ACT vs. SCCM) by time effects on a self-report measure of medication adherence. Adherence was dichotomized as 20% or more missed medication days (&quot;poor adherence&quot;) versus less than 20% missed medication days (&quot;adequate adherence&quot;).  RESULTS: Participants who were assigned to ACT reported significant improvement in medication adherence compared with those assigned to SCCM. CONCLUSIONS: Integrated treatment delivered via ACT may benefit persons with co-occurring psychotic and substance use disorders who are poorly adherent to medications.<p />",
language="",
issn="1078-3903",
doi="10.1177/1078390310395586",
url="http://dx.doi.org/10.1177/1078390310395586"
}